Skip to content
★ Sign in to follow
Cogstate Ltd logo

Cogstate Ltd Stock: price and insider trades · Australia

ISIN AU000000CGS8AU·Mcap A$602.4MHealth Care

1 insider bought €33k of shares over the last 90 days, the latest by Darryl Inns, filed 26 Oct 2026.

Cogstate Ltd: what insiders have been doing

Headquartered in Melbourne, Australia, Cogstate Ltd belongs to the Health Care sector. Filings by its managers are published through ASX. From 2 November 2025 to 2 November 2026, the disclosure feed for Cogstate Ltd logged 4 filings by 3 insiders.

Only purchases show up on the open market, 1 purchase in all worth €33k, filed by 1 insider. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Among those who bought: 1 senior executive. The largest single trade was a purchase of €33k by Darryl Inns, published on 26 October 2026, equal to 0.0087% of the market capitalisation.

Across the 1,612 companies tracked on its exchange, the median is 5 filings; at 4 filings, this issuer sits below that mark. Our records for Cogstate Ltd go back to 2026, with 1 purchase and no sales on the open market in total.

The most recent open-market purchase was published on 26 October 2026, 12 days ago. Filings reach the ASX feed a median of 3 days after the trade. The shorter that gap, the sooner other investors can see what insiders have done.

In the same sector, recent insider purchases at Dynavox Group AB and UCB also feature in our signals. Source: insider filings from ASX. Past trades are no guide to future returns.

Key facts

Headquarters: Melbourne, Australia

Source: Wikidata (CC0).

Insider Decl.
4
Thresholds
n/a
Buy Volume
€32,891
1 ops. · all time
Sell Volume
n/a
n/a

Who traded when

BuySale
Darryl Inns1 buy

Analyst consensus: bullish or bearish?

Analysts rate Cogstate Ltd Strong Buy (bullish), based on 4 analysts. Average price target: A$4.50.

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 9,063 of 26,897 companies
59.7
score / 100
Value
31
Quality
88
FCF yld0.4%
Earn yld2.0%
EV/EBITDA31.4x
ROE22%
Gross mgn58%
Net mgn20%
Debt/EBITDA0.0x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2026

FY ended June 2026 · cache

A$3.50
Analyst consensus
4 analysts
Strong buy
A$3.99Target A$4.50(+28%)A$5.80
Income statement
RevenueA$58.4M
Gross profitA$33.9M58% margin
EBITDAA$19.2M33% margin
Net incomeA$11.9M19.5% margin
Valuation
PER (trailing)35.0x
PER (forward)21.9x
P/Book7.1x
Beta0.27
Balance sheet & cash
Market capA$602.4M
Total debtA$359.2k
Free Cash FlowA$2.2M
Debt / Equity1%
Profitability & ownership
ROE22.5%
ROA12.6%
% insiders40.5%
% institutions16.7%
Last declaration on 1 November 2026
Declarations4 total
  • ●
    DirectorExecutives
    1M AUD0ASX
    0@ A$2.9476ShareASXISIN AU000000CGS8ASX:2924-03156835-3A705590
  • ●
    DirectorExecutives
    3M AUD37ASX
    0@ A$5.69140.47% mcap100.0% of flowShareASXASX:2924-03155142-3A705319
  • ▲
    DirectorExecutives
    52,618 AUD28ASX
    15,000 shares@ A$3.50780.0087% mcap100.0% of flowShareASXISIN AU000000CGS8ASX:2924-03153411-3A705006
    Canonical exit: 21 Jan 2027 (T+90)
  • ●
    Substantial HolderExecutives(filed)
    0ASX
    ShareASXISIN AU000000CGS8ASX:2924-03107463-3A696586

4 of 4 declarations

About Cogstate Ltd

Cogstate Ltd is a company listed on the XASX, specializing in cognitive assessment solutions. It develops tools to measure cognitive function and mental well-being.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations